Profile: Salix Pharmaceuticals

Return

Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases and disorders. We are focused on constantly innovating to improve patients’ lives. We gain a deeper understanding of the GI conditions our products treat by connecting with the patients who use them and the healthcare professionals (HCPs) who prescribe them. Our therapeutic areas of expertise include overt hepatic encephalopathy, irritable bowel syndrome with diarrhea, irritable bowel syndrome with constipation, chronic idiopathic constipation, opioid-induced constipation, bowel preparation and ulcerative colitis.

  • Wes Dorey
    Director, Institutional Accounts, Mid-Atlantic
  • Brian Henderson
    Director, Institutional Accounts, TX, OK
  • Bill Gagliardi
    Senior Director of Marketing
  • Mark Van Fleet
    Director of GPO & Institution Accounts
  • Aaron Samson
    HEOR fellow - Medical Affairs
  • Kate Kim
    Medical Science Liaison
[ Feedback → ]